LIGAND PHARMACEUTICALS INCORPORATED
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 7.0% | 7.0% | 4.4% |
| FY2022 | -5.6% | -5.6% | -4.4% |
| FY2023 | 7.4% | 7.4% | 6.6% |
| FY2024 | -0.5% | -0.5% | -0.4% |
| FY2025 | 12.2% | 12.2% | 8.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 7.0% | 7.0% | 4.4% |
| FY2022 | -5.6% | -5.6% | -4.4% |
| FY2023 | 7.4% | 7.4% | 6.6% |
| FY2024 | -0.5% | -0.5% | -0.4% |
| FY2025 | 12.2% | 12.2% | 8.0% |